In vivo assessment of pulmonary fibrosis and edema in rodents using the backscatter coefficient and envelope statistics

Lung Ultrasound Spectroscopy Applied to the Differential Diagnosis of Pulmonary Diseases: An In Vivo Multicenter Clinical Study

Lung ultrasound (LUS) is an important imaging modality to assess the state of the lung surface. However, current LUS approaches are based on subjective interpretation of imaging artifacts, which results in poor specificity as quantitative evaluation lacks. The latter could be improved by adopting LUS spectroscopy of vertical artifacts. Indeed, parameterizing these artifacts with native frequency, bandwidth, and total intensity ( [Formula: see text]) already showed potentials in differentiating pulmonary fibrosis (PF). In this study, we acquired radio frequency (RF) data from 114 patients. These data (representing the largest LUS RF dataset worldwide) were acquired by utilizing a multifrequency approach, implemented with an ULtrasound Advanced Open Platform (ULA-OP). Convex (CA631) and linear (LA533) probes (Esaote, Florence, Italy) were utilized to acquire RF data at three (2, 3, and 4 MHz), and four (3, 4, 5, and 6 MHz) imaging frequencies. A multifrequency analysis was conducted on vertical artifacts detected in patients having cardiogenic pulmonary edema (CPE), pneumonia, or PF. These artifacts were characterized by the three abovementioned parameters, and their mean values were used to project each patient into a feature space having up to three dimensions. Binary classifiers were used to evaluate the performance of these three mean features in differentiating patients affected by CPE, pneumonia, and PF. Acquisitions of multifrequency data performed with linear probe lead to accuracies up to 85.43% in the differential diagnosis of these diseases (convex probes' maximum accuracy was 74.51%). Moreover, the results showed high potentials of mean [Formula: see text] (by itself or combined with other features) in improving LUS specificity.

Changes in mechanical properties at the muscle level could be detected by Nakagami imaging during in-vivo fixed-end contractions

In this study, we investigated the capability of the Nakagami transformation to detect changes in vastus lateralis muscle-tendon stiffness (k) during dynamic (and intense) contractions. k was evaluated in eleven healthy males using the gold-standard method (a combination of ultrasound and dynamometric measurements) during maximal and sub-maximal voluntary fixed-end contractions of the knee extensors (20, 40, 60, 80, and 100% of maximum voluntary force), while Nakagami parameters were analysed using the Nakagami transformation during the same contractions. Muscle-belly behaviour was investigated by means of B-mode ultrasound analysis, while Nakagami parameters were obtained in post-processing using radiofrequency data. k was calculated as the slope of the force-muscle-belly elongation relationship. Three contractions at each intensity were performed to calculate the intra-trial reliability and the coefficient of variation (CV) of the Nakagami parameters. At all contraction intensities, high values of intra-trial reliability (range: 0.92-0.96) and low CV (<9%) were observed. k and Nakagami parameters increased as a function of contraction intensity, and significant positive correlations were observed between these variables. These data suggest that changes in mechanical properties (e.g., stiffness) at the muscle level could be investigated by means of Nakagami parameters.

Lung quantitative ultrasound to stage and monitor interstitial lung diseases

Chronic interstitial lung diseases (ILDs) require frequent point-of-care monitoring. X-ray-based methods lack resolution and are ionizing. Chest computerized tomographic (CT) scans are expensive and provide more radiation. Conventional ultrasound can detect severe lung damage via vertical artifacts (B-lines). However, this information is not quantitative, and the appearance of B-lines is operator- and system-dependent. Here we demonstrate novel ultrasound-based biomarkers to assess severity of ILDs. Lung alveoli scatter ultrasound waves, leading to a complex acoustic signature, which is affected by changes in alveolar density due to ILDs. We exploit ultrasound scattering in the lung and combine quantitative ultrasound (QUS) parameters, to develop ultrasound-based biomarkers that significantly correlate (p = 1e-4 for edema and p = 3e-7 for fibrosis) to the severity of pulmonary fibrosis and edema in rodent lungs. These innovative QUS biomarkers will be very significant for monitoring severity of chronic ILDs and response to treatment, especially in this new era of miniaturized and highly portable ultrasound devices.

Lung Quantitative Ultrasound to Stage and Monitor Interstitial Lung Diseases

Chronic interstitial lung diseases (ILDs) require frequent point-of-care monitoring. X-ray-based methods lack resolution and are ionizing. Chest computerized tomographic (CT) scans are expensive and provide more radiation. Conventional ultrasound can detect severe lung damage via vertical artifacts (B-lines). However, this information is not quantitative, and the appearance of B-lines is operator- and system-dependent. Here we demonstrate novel ultrasound-based biomarkers to assess severity of ILDs. Lung alveoli scatter ultrasound waves, leading to a complex acoustic signature, which is affected by changes in alveolar density due to ILDs. We exploit ultrasound scattering in the lung and combine Quantitative Ultrasound (QUS) parameters, to develop ultrasound-based biomarkers that significantly correlate to the severity of pulmonary fibrosis and edema in rodent lungs. These innovative QUS biomarkers will be very significant for monitoring severity of chronic ILDs and response to treatment, especially in this new era of miniaturized and highly portable ultrasound devices.

Parallelized ultrasound homodyned-K imaging based on a generalized artificial neural network estimator

The homodyned-K (HK) distribution model is a generalized backscatter envelope statistical model for ultrasound tissue characterization, whose parameters are of physical meaning. To estimate the HK parameters is an inverse problem, and is quite complicated. Previously, we proposed an artificial neural network (ANN) estimator and an improved ANN (iANN) estimator for estimating the HK parameters, which are fast and flexible. However, a drawback of the conventional ANN and iANN estimators consists in that they use Monte Carlo simulations under known values of HK parameters to generate training samples, and thus the ANN and iANN models have to be re-trained when the size of the test sets (or of the envelope samples to be estimated) varies. In addition, conventional ultrasound HK imaging uses a sliding window technique, which is non-vectorized and does not support parallel computation, so HK image resolution is usually sacrificed to ensure a reasonable computation cost. To this end, we proposed a generalized ANN (gANN) estimator in this paper, which took the theoretical derivations of feature vectors for network training, and thus it is independent from the size of the test sets. Further, we proposed a parallelized HK imaging method that is based on the gANN estimator, which used a block-based parallel computation method, rather than the conventional sliding window technique. The gANN-based parallelized HK imaging method allowed a higher image resolution and a faster computation at the same time. Computer simulation experiments showed that the gANN estimator was generally comparable to the conventional ANN estimator in terms of HK parameter estimation performance. Clinical experiments of hepatic steatosis showed that the gANN-based parallelized HK imaging could be used to visually and quantitatively characterize hepatic steatosis, with similar performance to the conventional ANN-based HK imaging that used the sliding window technique, but the gANN-based parallelized HK imaging was over 3 times faster than the conventional ANN-based HK imaging. The parallelized computation method presented in this work can be easily extended to other quantitative ultrasound imaging applications.

Current Advances in Computational Lung Ultrasound Imaging: A Review

In the field of biomedical imaging, ultrasonography has become common practice, and used as an important auxiliary diagnostic tool with unique advantages, such as being non-ionizing and often portable. This article reviews the state-of-the-art in medical ultrasound (US) image processing and in particular its applications in the examination of the lungs. First, we briefly introduce the basis of lung US (LUS) examination. We focus on (i) the characteristics of lung ultrasonography and (ii) its ability to detect a variety of diseases through the identification of various artifacts exhibiting on LUS images. We group medical US image computing methods into two categories: 1) model-based methods and 2) data-driven methods. We particularly discuss inverse problem-based methods exploited in US image despeckling, deconvolution, and line artifacts detection for the former, while we exemplify various works based on deep/machine learning (ML), which exploit various network architectures through supervised, weakly supervised, and unsupervised learning for the data-driven approaches.

State of the Art in Lung Ultrasound, Shifting from Qualitative to Quantitative Analyses

Lung ultrasound (LUS) has been increasingly expanding since the 1990s, when the clinical relevance of vertical artifacts was first reported. However, the massive spread of LUS is only recent and is associated with the coronavirus disease 2019 (COVID-19) pandemic, during which semi-quantitative computer-aided techniques were proposed to automatically classify LUS data. In this review, we discuss the state of the art in LUS, from semi-quantitative image analysis approaches to quantitative techniques involving the analysis of radiofrequency data. We also discuss recent in vitro and in silico studies, as well as research on LUS safety. Finally, conclusions are drawn highlighting the potential future of LUS.

Introduction to the special issue on lung ultrasound

The potential of lung ultrasound (LUS) has become manifest in the light of the recent COVID-19 pandemic. The need for a point-of care, quantitative, and widely available assessment of lung condition is critical. However, conventional ultrasound imaging was never designed for lung assessment. This limits LUS to the subjective and qualitative interpretation of artifacts and imaging patterns visible on ultrasound images. A number of research groups have begun to tackle this limitation, and this special issue reports on their most recent findings. Through in silico, in vitro, and in vivo studies (preclinical animal studies and pilot clinical studies on human subjects), the research presented aims at understanding and modelling the physical phenomena involved in ultrasound propagation, and at leveraging these phenomena to extract semi-quantitative and quantitative information relevant to estimate changes in lung structure. These studies are the first steps in unlocking the full potential of lung ultrasound as a relevant tool for lung assessment.